氯雷他嗪衍生的烷基化物质产生的DNA链间交联对白血病细胞系的致死性。
Lethality to leukemia cell lines of DNA interstrand cross-links generated by Cloretazine derived alkylating species.
作者信息
Penketh Philip G, Baumann Raymond P, Ishiguro Kimiko, Shyam Krishnamurthy, Seow Helen A, Sartorelli Alan C
机构信息
Department of Pharmacology and Developmental Therapeutics Program, Cancer Center, Yale University School of Medicine, New Haven, CT 06520, USA.
出版信息
Leuk Res. 2008 Oct;32(10):1546-53. doi: 10.1016/j.leukres.2008.03.005. Epub 2008 May 13.
Abstract
Cloretazine [1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine; VNP40101M; 101M] is a relatively new prodrug with activity in elderly acute myelogenous leukemia (AML) patients. Its therapeutic action is due largely to the production of 1-(3-cytosinyl),2-(1-guanyl)ethane cross-links (G-C ethane cross-links) in DNA. The numbers of cross-links produced in three experimental leukemia lines (L1210, U937 and HL-60) were fewer than 10 per genome at their respective LC50 concentrations. Only 1 in approximately 20,000 90CE molecules produces a cross-link in the AGT (O6-alkylguanine-DNA alkyltransferase) negative L1210 and U937 cell lines and 1 in 400,000 in the AGT positive HL-60 cell line.
摘要
氯雷他嗪[1,2 - 双(甲基磺酰基)-1-(2 - 氯乙基)-2 - [(甲氨基)羰基]肼；VNP40101M；101M]是一种相对较新的前体药物，对老年急性髓性白血病(AML)患者具有活性。其治疗作用主要归因于在DNA中产生1-(3 - 胞嘧啶基)，2-(1 - 鸟嘌呤基)乙烷交联(G - C乙烷交联)。在三种实验性白血病细胞系(L1210、U937和HL - 60)中，在各自的半数致死浓度(LC50)下，每个基因组产生的交联数少于10个。在AGT( O6 - 烷基鸟嘌呤 - DNA烷基转移酶)阴性的L1210和U937细胞系中，大约20,000个90CE分子中只有1个产生交联，而在AGT阳性的HL - 60细胞系中，400,000个分子中才有1个产生交联。
相似文献
1
Lethality to leukemia cell lines of DNA interstrand cross-links generated by Cloretazine derived alkylating species.氯雷他嗪衍生的烷基化物质产生的DNA链间交联对白血病细胞系的致死性。
Leuk Res. 2008 Oct;32(10):1546-53. doi: 10.1016/j.leukres.2008.03.005. Epub 2008 May 13.
2
Mode of action of the chloroethylating and carbamoylating moieties of the prodrug cloretazine.前药氯雷他嗪的氯乙基化和氨基甲酰化部分的作用模式。
Mol Cancer Ther. 2006 Apr;5(4):969-76. doi: 10.1158/1535-7163.MCT-05-0532.
3
Role of O6-alkylguanine-DNA alkyltransferase in the cytotoxic activity of cloretazine.O6-烷基鸟嘌呤-DNA烷基转移酶在氯雷他嗪细胞毒性活性中的作用。
Mol Cancer Ther. 2005 Nov;4(11):1755-63. doi: 10.1158/1535-7163.MCT-05-0169.
4
The antineoplastic efficacy of the prodrug Cloretazine is produced by the synergistic interaction of carbamoylating and alkylating products of its activation.前药氯雷他嗪的抗肿瘤功效是由其活化产生的氨甲酰化和烷基化产物的协同相互作用所产生的。
Oncol Res. 2005;15(6):313-25. doi: 10.3727/096504005776404553.
5
Influence of glutathione and glutathione S-transferases on DNA interstrand cross-link formation by 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine, the active anticancer moiety generated by laromustine.谷胱甘肽和谷胱甘肽S-转移酶对1,2-双（甲基磺酰基）-1-（2-氯乙基）肼（洛莫司汀产生的活性抗癌部分）形成DNA链间交联的影响。
Chem Res Toxicol. 2014 Aug 18;27(8):1440-9. doi: 10.1021/tx500197t. Epub 2014 Jul 17.
6
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): II. Role of O6-alkylguanine-DNA alkyltransferase in cytotoxicity.1,2-双（甲基磺酰基）-1-（2-氯乙基）-2-[(甲氨基)羰基]肼（VNP40101M）：II. O6-烷基鸟嘌呤-DNA烷基转移酶在细胞毒性中的作用
Cancer Chemother Pharmacol. 2004 Apr;53(4):288-95. doi: 10.1007/s00280-003-0739-0. Epub 2003 Dec 17.
7
pH-dependent general base catalyzed activation rather than isocyanate liberation may explain the superior anticancer efficacy of laromustine compared to related 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine prodrugs.可能是 pH 依赖性的广义碱催化激活而不是异氰酸酯释放，解释了拉罗司汀相对于相关的 1,2-双（甲基磺酰基）-1-（2-氯乙基）肼前药具有更好的抗癌疗效。
Chem Biol Drug Des. 2018 Jan;91(1):62-74. doi: 10.1111/cbdd.13057. Epub 2017 Jul 17.
8
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): I. Direct inhibition of O6-alkylguanine-DNA alkyltransferase (AGT) by electrophilic species generated by decomposition.1,2-双（甲基磺酰基）-1-（2-氯乙基）-2-[(甲氨基)羰基]肼（VNP40101M）：I. 分解产生的亲电物质对O6-烷基鸟嘌呤-DNA烷基转移酶（AGT）的直接抑制作用
Cancer Chemother Pharmacol. 2004 Apr;53(4):279-87. doi: 10.1007/s00280-003-0740-7. Epub 2003 Dec 24.
9
Chloroethylating and methylating dual function antineoplastic agents display superior cytotoxicity against repair proficient tumor cells.具有烷化和甲基化双重功能的抗肿瘤药物对修复能力强的肿瘤细胞显示出更强的细胞毒性。
Bioorg Med Chem Lett. 2013 Mar 15;23(6):1853-9. doi: 10.1016/j.bmcl.2013.01.016. Epub 2013 Jan 11.
10
Reductive activation of the prodrug 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119) selectively occurs in oxygen-deficient cells and overcomes O(6)-alkylguanine-DNA alkyltransferase mediated KS119 tumor cell resistance.前药 1,2-双（甲磺酰基）-1-（2-氯乙基）-2-[[1-（4-硝基苯基）乙氧基]羰基]酰肼（KS119）的还原激活仅在缺氧细胞中发生，并克服了 O(6)-烷基鸟嘌呤-DNA 烷基转移酶介导的 KS119 肿瘤细胞耐药性。
Biochem Pharmacol. 2010 Jun 1;79(11):1553-61. doi: 10.1016/j.bcp.2009.12.004. Epub 2009 Dec 11.
引用本文的文献
1
Design Strategy for the EPR Tumor-Targeting of 1,2-Bis(sulfonyl)-1-alkylhydrazines.1,2-双（磺酰基）-1-烷基腙的 EPR 肿瘤靶向设计策略。
Molecules. 2021 Jan 6;26(2):259. doi: 10.3390/molecules26020259.
2
Physicochemical Considerations of Tumor Selective Drug Delivery and Activity Confinement with Particular Reference to 1,2-Bis(Sulfonyl)-1- Alkylhydrazines Delivery.肿瘤选择性药物传递的物理化学考虑因素及活性限制，特别参考 1,2-双（磺酰基）-1-烷基酰肼的传递。
Curr Drug Deliv. 2020;17(5):362-374. doi: 10.2174/1567201817666200427215044.
3
pH-dependent general base catalyzed activation rather than isocyanate liberation may explain the superior anticancer efficacy of laromustine compared to related 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine prodrugs.可能是 pH 依赖性的广义碱催化激活而不是异氰酸酯释放，解释了拉罗司汀相对于相关的 1,2-双（甲基磺酰基）-1-（2-氯乙基）肼前药具有更好的抗癌疗效。
Chem Biol Drug Des. 2018 Jan;91(1):62-74. doi: 10.1111/cbdd.13057. Epub 2017 Jul 17.
4
Influence of glutathione and glutathione S-transferases on DNA interstrand cross-link formation by 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine, the active anticancer moiety generated by laromustine.谷胱甘肽和谷胱甘肽S-转移酶对1,2-双（甲基磺酰基）-1-（2-氯乙基）肼（洛莫司汀产生的活性抗癌部分）形成DNA链间交联的影响。
Chem Res Toxicol. 2014 Aug 18;27(8):1440-9. doi: 10.1021/tx500197t. Epub 2014 Jul 17.
5
Influence of phosphate and phosphoesters on the decomposition pathway of 1,2-bis(methylsulfonyl)-1-(2-chloroethyhydrazine (90CE), the active anticancer moiety generated by Laromustine, KS119, and KS119W.磷酸盐和磷酸酯对1,2 - 双（甲基磺酰基）-1 - （2 - 氯乙基）肼（90CE）分解途径的影响，90CE是洛莫司汀、KS119和KS119W产生的活性抗癌部分。
Chem Res Toxicol. 2014 May 19;27(5):818-33. doi: 10.1021/tx500004y. Epub 2014 Mar 24.
6
Chloroethylating and methylating dual function antineoplastic agents display superior cytotoxicity against repair proficient tumor cells.具有烷化和甲基化双重功能的抗肿瘤药物对修复能力强的肿瘤细胞显示出更强的细胞毒性。
Bioorg Med Chem Lett. 2013 Mar 15;23(6):1853-9. doi: 10.1016/j.bmcl.2013.01.016. Epub 2013 Jan 11.
7
Thioredoxin reductase is inhibited by the carbamoylating activity of the anticancer sulfonylhydrazine drug laromustine.硫氧还蛋白还原酶可被抗癌磺酰肼药物拉罗司汀的氨甲酰化活性抑制。
Mol Cell Biochem. 2012 Nov;370(1-2):199-207. doi: 10.1007/s11010-012-1411-y. Epub 2012 Aug 5.
8
Preclinical evaluation of Laromustine for use in combination with radiation therapy in the treatment of solid tumors.拉罗曲塞联合放疗治疗实体瘤的临床前评估。
Int J Radiat Biol. 2012 Mar;88(3):277-85. doi: 10.3109/09553002.2012.638359. Epub 2011 Dec 20.
9
4-nitrobenzyloxycarbonyl derivatives of O(6)-benzylguanine as hypoxia-activated prodrug inhibitors of O(6)-alkylguanine-DNA alkyltransferase (AGT), which produces resistance to agents targeting the O-6 position of DNA guanine.4-硝基苄氧羰基氧(6)-苄基鸟嘌呤衍生物作为缺氧激活前药抑制剂的 O(6)-烷基鸟嘌呤-DNA 烷基转移酶 (AGT)，它产生对靶向 DNA 鸟嘌呤 O-6 位置的试剂的抗性。
J Med Chem. 2011 Nov 10;54(21):7720-8. doi: 10.1021/jm201115f. Epub 2011 Oct 17.
10
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119): a cytotoxic prodrug with two stable conformations differing in biological and physical properties.1,2-双(甲磺酰基)-1-(2-氯乙基)-2-[[1-(4-硝基苯基)乙氧基]羰基]酰肼（KS119）：一种具有两种稳定构象的细胞毒性前药，在生物学和物理性质上有所不同。
Chem Biol Drug Des. 2011 Oct;78(4):513-26. doi: 10.1111/j.1747-0285.2011.01193.x. Epub 2011 Sep 6.
本文引用的文献
1
The anatomy of viral DNA molecules.病毒DNA分子的剖析
Annu Rev Biochem. 1967;36:485-518. doi: 10.1146/annurev.bi.36.070167.002413.
2
Mode of action of the chloroethylating and carbamoylating moieties of the prodrug cloretazine.前药氯雷他嗪的氯乙基化和氨基甲酰化部分的作用模式。
Mol Cancer Ther. 2006 Apr;5(4):969-76. doi: 10.1158/1535-7163.MCT-05-0532.
3
The antineoplastic efficacy of the prodrug Cloretazine is produced by the synergistic interaction of carbamoylating and alkylating products of its activation.前药氯雷他嗪的抗肿瘤功效是由其活化产生的氨甲酰化和烷基化产物的协同相互作用所产生的。
Oncol Res. 2005;15(6):313-25. doi: 10.3727/096504005776404553.
4
Phase I study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, combined with cytarabine in patients with refractory leukemia.新型磺酰肼烷化剂氯雷他嗪（VNP40101M）联合阿糖胞苷治疗难治性白血病的I期研究
Clin Cancer Res. 2005 Nov 1;11(21):7817-24. doi: 10.1158/1078-0432.CCR-05-1070.
5
Role of O6-alkylguanine-DNA alkyltransferase in the cytotoxic activity of cloretazine.O6-烷基鸟嘌呤-DNA烷基转移酶在氯雷他嗪细胞毒性活性中的作用。
Mol Cancer Ther. 2005 Nov;4(11):1755-63. doi: 10.1158/1535-7163.MCT-05-0169.
6
Biphasic behavior of changes in elemental composition during staurosporine-induced apoptosis.星形孢菌素诱导的细胞凋亡过程中元素组成变化的双相行为。
Apoptosis. 2005 Dec;10(6):1317-31. doi: 10.1007/s10495-005-2718-x.
7
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): I. Direct inhibition of O6-alkylguanine-DNA alkyltransferase (AGT) by electrophilic species generated by decomposition.1,2-双（甲基磺酰基）-1-（2-氯乙基）-2-[(甲氨基)羰基]肼（VNP40101M）：I. 分解产生的亲电物质对O6-烷基鸟嘌呤-DNA烷基转移酶（AGT）的直接抑制作用
Cancer Chemother Pharmacol. 2004 Apr;53(4):279-87. doi: 10.1007/s00280-003-0740-7. Epub 2003 Dec 24.
8
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): II. Role of O6-alkylguanine-DNA alkyltransferase in cytotoxicity.1,2-双（甲基磺酰基）-1-（2-氯乙基）-2-[(甲氨基)羰基]肼（VNP40101M）：II. O6-烷基鸟嘌呤-DNA烷基转移酶在细胞毒性中的作用
Cancer Chemother Pharmacol. 2004 Apr;53(4):288-95. doi: 10.1007/s00280-003-0739-0. Epub 2003 Dec 17.
9
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs.基于60770个全长cDNA功能注释的小鼠转录组分析。
Nature. 2002 Dec 5;420(6915):563-73. doi: 10.1038/nature01266.
10
Initial sequencing and comparative analysis of the mouse genome.小鼠基因组的初步测序与比较分析。
Nature. 2002 Dec 5;420(6915):520-62. doi: 10.1038/nature01262.
Zotero 插件